Mangoceuticals Inc
NASDAQ:MGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
US |
Intrinsic Value
The intrinsic value of Mangoceuticals Inc (MGRX) under the Base Case is 0.0218 USD per share. Compared with the current market price of 0.2443 USD, the stock appears Overvalued by 91% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Mangoceuticals Does
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg).
- Headquarters
- United States of America US
- IPO date
- Mar 21, 2023
Earnings Waterfall
Mangoceuticals Inc
The intrinsic value for Mangoceuticals Inc (MGRX) under the Base Case is 0.0218 USD.
Compared with the current market price of 0.2443 USD, the stock appears Overvalued by 91% .